Unexplained weight loss (UWL) is a frequent clinical challenge for physicians. It is often associated with underlying serious conditions, including malignancies, gastrointestinal disorders, and endocrine abnormalities. This article aims to provide a comprehensive approach to the evaluation and management of UWL in clinical practice.
UWL can be a manifestation of multiple pathologies. The most common causes include malignancies, chronic infections, gastrointestinal disorders, and endocrine abnormalities. The pathophysiology of UWL is multifactorial and often involves a combination of reduced caloric intake, increased metabolic rate, and malabsorption.
A thorough history and physical examination are essential in the assessment of UWL. The history should focus on the duration of weight loss, associated symptoms, and risk factors for specific diseases. Physical examination should include a comprehensive systemic evaluation to identify any signs of underlying disease.
The diagnostic approach to UWL should be guided by the clinical assessment. Initial investigations may include a complete blood count, metabolic panel, thyroid function tests, and imaging studies. Further investigations should be directed by the initial findings and may include endoscopy, biopsy, or specialized imaging studies.
Management of UWL is primarily directed towards treating the underlying cause. Nutritional support and symptom management are also important aspects of patient care. Early diagnosis and treatment can significantly improve patient outcomes.
UWL is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations are crucial in identifying the underlying cause. Timely diagnosis and management can significantly improve patient outcomes and quality of life.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation